Dr Catherine Freeman, DO in Portland, ME - Medicare Hospitalist

Dr Catherine Freeman, DO is a medicare enrolled "Hospitalist" physician in Portland, Maine. Her current practice location is 22 Bramhall St, Portland, Maine. You can reach out to her office (for appointments etc.) via phone at (207) 662-4618.

Dr Catherine Freeman is licensed to practice in Maine (license number DO3392) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1023570074.

Contact Information

	Dr Catherine Freeman, DO
	22 Bramhall St, Portland, ME 04102-3134
	(207) 662-4618
	Not Available

Physician's Profile

Full Name	Dr Catherine Freeman
Gender	Female
Speciality	Hospitalist
Location	22 Bramhall St, Portland, Maine
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1023570074
Provider Enumeration Date: 04/01/2019
Last Update Date: 08/04/2022

Medicare PECOS Information:

PECOS PAC ID: 7416283767
Enrollment ID: I20220825002756

Medical Identifiers

Medical identifiers for Dr Catherine Freeman such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1023570074	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208M00000X	Hospitalist	DO3392 (Maine)	Primary
207R00000X	Internal Medicine	DO3392 (Maine)	Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Catherine Freeman allows following entities to bill medicare on her behalf.

Entity Name	Mainehealth
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166

News Archive

Pfizer,DNDi partner to Identify NTD drugs; Sanofi-Aventis, medicines for malaria launch drug study

Pfizer and the Drugs for Neglected Diseases Initiative (DNDi) on Wednesday announced plans to team up in an effort to identify new drug candidates for the treatment of three tropical diseases, the Associated Press/Business Week reports. The scientists will test the efficacy of Pfizer drug candidates against sleeping sickness, visceral leishmaniasis, and Chagas disease.

AMA Task Force to Reduce Opioid Abuse announces national recommendations to address opioid crisis

Opioid abuse is a serious public health problem that has reached crisis levels across the United States, with 44 people dying each day from overdose of opioids, and many more becoming addicted. Recognizing the urgency and serious impact of this issue on the health of hundreds of thousands of patients across the country, today the American Medical Association Task Force to Reduce Opioid Abuse announced the first of several national recommendations to address this growing epidemic.

Suicide rates are increasing, especially among rural Americans

Suicide is becoming more common in America, an increase most pronounced in rural areas, new research has found.

Varicella zoster infection causes severe autoimmune hepatitis

Autoimmune hepatitis (AIH) is a chronic liver inflammation of unknown etiology that is characterized by the presence of circulatory autoantibodies and ongoing liver tissue damage.

Shire announces FDA approval of Vyvanse Capsules for binge eating disorder

Shire plc announced today that the U.S. Food and Drug Administration approved Vyvanse (lisdexamfetamine dimesylate) Capsules (CII), the first and only medication for the treatment of moderate to severe binge eating disorder (B.E.D.) in adults, shown to significantly reduce the mean number of binge days per week.

Entity Name	Maine Medical Partners
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1073527388 PECOS PAC ID: 9335043967 Enrollment ID: O20050401000844

Pfizer,DNDi partner to Identify NTD drugs; Sanofi-Aventis, medicines for malaria launch drug study

AMA Task Force to Reduce Opioid Abuse announces national recommendations to address opioid crisis

Suicide rates are increasing, especially among rural Americans

Suicide is becoming more common in America, an increase most pronounced in rural areas, new research has found.

Varicella zoster infection causes severe autoimmune hepatitis

Autoimmune hepatitis (AIH) is a chronic liver inflammation of unknown etiology that is characterized by the presence of circulatory autoantibodies and ongoing liver tissue damage.

Shire announces FDA approval of Vyvanse Capsules for binge eating disorder

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Catherine Freeman is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Catherine Freeman, DO 22 Bramhall St, Portland, ME 04102-3134 Ph: (207) 662-4618	Dr Catherine Freeman, DO 22 Bramhall St, Portland, ME 04102-3134 Ph: (207) 662-4618

News Archive

Pfizer,DNDi partner to Identify NTD drugs; Sanofi-Aventis, medicines for malaria launch drug study

AMA Task Force to Reduce Opioid Abuse announces national recommendations to address opioid crisis

Suicide rates are increasing, especially among rural Americans

Suicide is becoming more common in America, an increase most pronounced in rural areas, new research has found.

Varicella zoster infection causes severe autoimmune hepatitis

Autoimmune hepatitis (AIH) is a chronic liver inflammation of unknown etiology that is characterized by the presence of circulatory autoantibodies and ongoing liver tissue damage.

Shire announces FDA approval of Vyvanse Capsules for binge eating disorder

Hospitalist Doctors in Portland, ME

Karin M Doehne, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 211 Marginal Way, Portland, ME 04101 Phone: 207-544-9355
Elizabeth Clare Cummings, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-0111
Lisa Almeder, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Pavilion 1203, Portland, ME 04102 Phone: 207-662-4618 Fax: 207-662-6254
Mary C. Ottolini, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-6711 Fax: 207-662-6063
Dr. Lauren Nicole Boehm, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-0111
Monica Thim, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-0111

Dr Catherine Freeman, DO - Medicare Hospitalist in Portland, ME

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Pfizer,DNDi partner to Identify NTD drugs; Sanofi-Aventis, medicines for malaria launch drug study

AMA Task Force to Reduce Opioid Abuse announces national recommendations to address opioid crisis

Suicide rates are increasing, especially among rural Americans

Varicella zoster infection causes severe autoimmune hepatitis

Shire announces FDA approval of Vyvanse Capsules for binge eating disorder

Pfizer,DNDi partner to Identify NTD drugs; Sanofi-Aventis, medicines for malaria launch drug study

AMA Task Force to Reduce Opioid Abuse announces national recommendations to address opioid crisis

Suicide rates are increasing, especially among rural Americans

Varicella zoster infection causes severe autoimmune hepatitis

Shire announces FDA approval of Vyvanse Capsules for binge eating disorder

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Pfizer,DNDi partner to Identify NTD drugs; Sanofi-Aventis, medicines for malaria launch drug study

AMA Task Force to Reduce Opioid Abuse announces national recommendations to address opioid crisis

Suicide rates are increasing, especially among rural Americans

Varicella zoster infection causes severe autoimmune hepatitis

Shire announces FDA approval of Vyvanse Capsules for binge eating disorder

Hospitalist Doctors in Portland, ME